Scarica l'app Stockscreener
18.85
1.24%
0.23
Pre-mercato:
18.79
-0.06
-0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARQT Giù?
Forum
Previsione
Arcutis Biotherapeutics Inc Borsa (ARQT) Ultime notizie
Will Arcutis Biotherapeutics Inc. stock split attract more investorsEarnings Growth Summary & Reliable Price Breakout Signals - newser.com
Dermatology Leader Arcutis Announces Strategic Growth Plan Reveal at October Investor Day - Stock Titan
Arcutis Biotherapeutics (NASDAQ:ARQT) Hits New 52-Week HighWhat's Next? - MarketBeat
Arcutis Biotherapeutics stock hits 52-week high at 18.17 USD By Investing.com - Investing.com Canada
Arcutis Biotherapeutics stock hits 52-week high at 18.17 USD - Investing.com India
Are Medical Stocks Lagging Arcutis Biotherapeutics (ARQT) This Year? - Yahoo Finance
What drives Arcutis Biotherapeutics Inc stock priceEx-Dividend Date Alerts & High Yield Trading Growth - earlytimes.in
Is Arcutis Biotherapeutics Inc. stock reversal real or fakeWeekly Trend Report & Community Trade Idea Sharing Platform - newser.com
Here's Why Arcutis Biotherapeutics, Inc. (ARQT) is a Great Momentum Stock to Buy - Yahoo Finance
Arcutis Biotherapeutics, Inc.'s (NASDAQ:ARQT) Share Price Not Quite Adding Up - 富途牛牛
Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 30.94% Potential Upside Amidst Robust Revenue Growth - DirectorsTalk Interviews
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Trading 4.5% HigherHere's What Happened - MarketBeat
29,244 Shares in Arcutis Biotherapeutics, Inc. $ARQT Purchased by Triumph Capital Management - MarketBeat
Bull Run: Why is Arcutis Biotherapeutics Inc. stock going upQuarterly Market Review & Real-Time Chart Pattern Alerts - خودرو بانک
Published on: 2025-09-20 11:38:58 - خودرو بانک
Stock Analysis: Is Arcutis Biotherapeutics Inc stock good for income investors2025 Trading Volume Trends & Weekly Chart Analysis and Guides - خودرو بانک
Analyst Upgrade: What is Arcutis Biotherapeutics Inc. s 5 year growth outlookTrade Entry Summary & Community Driven Trade Alerts - خودرو بانک
EPS Watch: Can Viavi Solutions Inc maintain its current growth rateEarnings Risk Report & Weekly High Conviction Trade Ideas - khodrobank.com
Breakout Move: Can Arcutis Biotherapeutics Inc sustain earnings growthJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - خودرو بانک
Take Profit: What are the future prospects of Arcutis Biotherapeutics IncQuarterly Risk Review & Stepwise Trade Execution Plans - خودرو بانک
Anti-Aging Market Surges as $101M Competition Drives Demographic Revolution - baystreet.ca
Income Plays: Will FBLA face regulatory challengesRecession Risk & Reliable Intraday Trade Alerts - خودرو بانک
Invst LLC Makes New Investment in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis director Howard G. Welgus sells $127,100 in common stock - MSN
Market Review: Is ProShares Trust ProShares UltraPro Short S&P500 a good ESG investmentJuly 2025 WrapUp & Expert-Curated Trade Recommendations - خودرو بانک
CEO Change: Can NanoViricides Inc continue delivering strong returnsWeekly Risk Summary & Safe Entry Zone Tips - خودرو بانک
Arcutis Biotherapeutics (ARQT) Unveils Positive Data on Zoryve F - GuruFocus
Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress - The Manila Times
Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress | Dow Theory Letters - FinancialContent
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award - GlobeNewswire
79.5% Success Rate: Arcutis' ZORYVE Foam Proves Highly Effective for Seborrheic Dermatitis Across All Skin Types - Stock Titan
Fred Alger Management LLC Invests $568,000 in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
FOMO Trade: Does Arcutis Biotherapeutics Inc stock reflect fundamentals2025 Sector Review & Low Drawdown Trading Techniques - خودرو بانک
Arcutis Biotherapeutics’ ZORYVE Wins 2025 Allure Best of Beauty Breakthrough Award for Innovation in Dermatology - Quiver Quantitative
Aug Big Picture: Can Arcutis Biotherapeutics Inc stock outperform in a bear market2025 Dividend Review & AI Enhanced Trading Signals - خودرو بانک
#1 Prescribed Dermatology Treatment ZORYVE Wins Prestigious Allure Award for Revolutionary Skin Care - Stock Titan
Arcutis Biotherapeutics, Inc. (ARQT) Eyes Pediatric Expansion for ZORYVE Cream - MSN
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Todd Watanabe Sells 9,625 Shares - MarketBeat
Aug Reactions: Will Arcutis Biotherapeutics Inc. benefit from current market trendsMarket Performance Summary & Weekly Top Stock Performers List - خودرو بانک
Chipmakers Recap: Can Arcutis Biotherapeutics Inc sustain earnings growthJuly 2025 Reactions & Reliable Momentum Entry Alerts - خودرو بانک
What are analysts price targets for Arcutis Biotherapeutics Inc2025 Retail Activity & Safe Swing Trade Setup Alerts - خودرو بانک
Fund Flows: What are analysts price targets for Arcutis Biotherapeutics IncQuarterly Investment Review & Daily Profit Maximizing Tips - خودرو بانک
Market Outlook: Is Arcutis Biotherapeutics Inc. forming a bullish divergence2025 Technical Overview & Consistent Income Trade Recommendations - خودرو بانک
Earnings Risk: Is National Presto Industries Inc gaining market shareEarnings Summary Report & Consistent Profit Focused Trading Strategies - khodrobank.com
Published on: 2025-09-15 14:30:32 - خودرو بانک
Arcutis Biotherapeutics (NASDAQ:ARQT) Sets New 1-Year HighHere's Why - MarketBeat
What MACD signals say about Arcutis Biotherapeutics Inc.2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
Arcutis Biotherapeutics Inc. stock trend forecastPortfolio Value Report & Stock Portfolio Risk Control - newser.com
Measuring Arcutis Biotherapeutics Inc.’s beta against major indicesJuly 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Arcutis Biotherapeutics Inc. stock volume spike explainedTrade Signal Summary & Smart Swing Trading Alerts - newser.com
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):